undefined undefined
NaN.000
NaN.00%
Barinthus Biotherapeutics press release (NASDAQ:BRNS): Q1 GAAP EPS of -$0.40. As of March 31, 2024, cash, cash equivalents and restricted cash was $130.0 million, compared to $142.1 million as of Dece...
05-13 21:10
Barinthus Biotherapeutics (NASDAQ:BRNS) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.54) by 25.93 percent. This is a 16.67 percent increase over losses of $(0.48) per
05-13 20:19
Barinthus Biotherapeutics (NASDAQ:BRNS) said it has appointed Leon Hooftman as its chief medical officer. Hooftman joined the firm from specialist immune-oncology company, ISA Pharmaceuticals. More on...
05-01 19:59
Just because a business does not make any money, does not mean that the stock w...
04-05 20:39
Gainers Candel Therapeutics (NASDAQ:CADL) shares moved upwards by 64.3% to $2....
04-05 00:31
Gainers: ARCA biopharma ABIO +81%. Kintara Therapeutics KTRA +65%. Next.e.GO N.V. EGOX +45%. Vanda Pharmaceuticals VNDA +34%. Aurora Cannabis (ACB) +35%. Educational Development Corp. (EDUC) +29%. Env...
04-04 00:54
12月31日,Barinthus Biotherapeutics Plc(BRNS.US)公布财报,公告显示公司2023财年净利润为-73.63百万美元,同比减...
03-22 00:15
Barclays analyst Carter Gould maintained a Buy rating on Barinthus Biotherapeut...
03-21 16:55
Barinthus Biotherapeutics (NASDAQ:BRNS) reported its Q4 earnings results on Wed...
03-20 21:15
What is the target price for Barinthus Biotherapeutics (BRNS)? The latest pr...
2023-11-28 08:42